Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case–control study

BACKGROUND: Whilst other studies have reported the effectiveness of mRNA vaccination against hospitalisation, including emergency department or intensive care admission, few have assessed effectiveness against other more clinically robust indices of COVID-19 severity. METHODS: A prospective single-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatzilena, Anastasia, Hyams, Catherine, Challen, Rob, Marlow, Robin, King, Jade, Adegbite, David, Kinney, Jane, Clout, Madeleine, Maskell, Nick, Oliver, Jennifer, Danon, Leon, Finn, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728025/
https://www.ncbi.nlm.nih.gov/pubmed/36506791
http://dx.doi.org/10.1016/j.lanepe.2022.100552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728025/
https://www.ncbi.nlm.nih.gov/pubmed/36506791
http://dx.doi.org/10.1016/j.lanepe.2022.100552

Ejemplares similares